Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Goldman Sachs 46^th Annual Global Healthcare Conference, taking place June 9-11, 2025.

Read more at globenewswire.com